Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 19.30
+0.15 (0.78%)
At close: Aug 26, 2026
Vistin Pharma ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 70.21 | 74.75 | 62.75 | 45.6 | -4.72 | 24.87 |
Depreciation & Amortization | 24.04 | 22.53 | 19.03 | 17.35 | 12.28 | 10.61 |
Other Operating Activities | 19.81 | 21.09 | 17.7 | 12.92 | -1.29 | 7.13 |
Change in Accounts Receivable | -28.25 | -28.25 | -3.12 | 12.14 | -20.81 | -12.76 |
Change in Inventory | -5.47 | -5.47 | 3.51 | 3.28 | -40.54 | -11.12 |
Change in Other Net Operating Assets | 15.49 | -6.62 | 7.99 | -0.69 | 44.57 | -5.05 |
Operating Cash Flow | 95.83 | 78.04 | 107.86 | 90.59 | -10.51 | 13.68 |
Operating Cash Flow Growth | 2.16% | -27.65% | 19.06% | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -16.51 | -16.68 | -40.8 | -17.9 | -64.29 | -31.94 |
Other Investing Activities | 0.4 | 0.4 | 0.51 | 0.22 | 0.03 | 0.27 |
Investing Cash Flow | -16.12 | -16.29 | -40.3 | -17.68 | -64.26 | -31.68 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 45.14 | - |
Total Debt Issued | - | - | - | - | 45.14 | - |
Short-Term Debt Repaid | - | - | - | -45.14 | - | - |
Long-Term Debt Repaid | - | -0.88 | -1.2 | -0.9 | -2.59 | -0.84 |
Total Debt Repaid | -0.88 | -0.88 | -1.2 | -46.05 | -2.59 | -0.84 |
Net Debt Issued (Repaid) | -0.88 | -0.88 | -1.2 | -46.05 | 42.55 | -0.84 |
Common Dividends Paid | -44.34 | -55.43 | -77.59 | - | - | -22.17 |
Other Financing Activities | -28.82 | -1.81 | -2.19 | -2.1 | -2.09 | -0.29 |
Financing Cash Flow | -74.04 | -58.13 | -80.97 | -48.14 | 40.46 | -23.3 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | 0 | 0 | 0 |
Net Cash Flow | 5.67 | 3.62 | -13.41 | 24.77 | -34.31 | -41.29 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 79.32 | 61.35 | 67.05 | 72.69 | -74.8 | -18.26 |
Free Cash Flow Growth | 4.85% | -8.50% | -7.75% | - | - | - |
Free Cash Flow Margin | 18.36% | 13.56% | 15.61% | 16.58% | -24.54% | -6.55% |
Free Cash Flow Per Share | 1.79 | 1.38 | 1.51 | 1.64 | -1.69 | -0.41 |
Levered Free Cash Flow | 43.23 | 28.41 | 35.83 | 54.19 | -81.62 | -30.41 |
Unlevered Free Cash Flow | 46.08 | 29.63 | 37.29 | 55.61 | -80.28 | -30.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1.81 | 1.81 | 2.19 | 2.1 | 2.09 | 0.29 |
Change in Working Capital | -18.23 | -40.34 | 8.38 | 14.73 | -16.78 | -28.92 |